ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Net income 2018–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$16.1MFY2025 · since FY2018: -$19.3M → -$16.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.1M | +88.5% |
| FY2024 | -$140.0M | +46.6% |
| FY2023 | -$262.1M | +15.8% |
| FY2022 | -$311.5M | -50.9% |
| FY2021 | -$206.4M | -52.1% |
| FY2020 | -$135.7M | -223.1% |
| FY2019 | -$42.0M | -118.1% |
| FY2018 | -$19.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARQT financial trends
ARQT RevenueARQT Net marginARQT Gross profitARQT Gross marginARQT Operating incomeARQT Operating marginARQT Operating cash flowARQT Free cash flowARQT Capital expendituresARQT Return on equityARQT Stock buybacksARQT Dividends paidARQT Total assetsARQT Total liabilitiesARQT Shareholders’ equityARQT overview →